[Trial study of ampiox sodium used intravenously in the clinical picture of internal diseases].
Clinical efficiency of intravenous ampiox was shown. The drug was used mainly in the treatment of patients with bronchopulmonary diseases and other infections. The results of the treatment proved to be good and satisfactory in 12 out of 15 patients. In 3 severe patients the antibiotic therapy produced a temporary effect. The side effects were of allergic genesis and rapidly disappeared after discontinuation of the treatment and administration of tavegi or dimedrol. No phlebitis cases were observed.
D000667:Ampicillin / Q000008:administration & dosage* / Q000009:adverse effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D006801:Humans; D010068:Oxacillin / Q000008:administration & dosage* / Q000009:adverse effects; D011014:Pneumonia / Q000188:drug therapy*; D013997:Time Factors
D004338:Drug Combinations; D000667:Ampicillin; D010068:Oxacillin
Opyt izucheniia ampioksa-natriia pri ego vnutrivennom primenenii v klinike vnutrennyikh bolezneĭ.